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The pathogenesis of two Californian strains of myxoma virus (MSW and MSD) was examined in European rabbits (Oryctolagus cuniculus)
that were either susceptible to myxomatosis (laboratory rabbits) or had undergone natural selection for genetic resistance to myxomatosis
(Australian wild rabbits). MSW was highly lethal for both types of rabbits with average survival times of 7.3 and 9.4 days, respectively, and 100%
mortality. Classical clinical signs of myxomatosis were not present except in one rabbit that survived for 13 days following infection. Previously
described clinical signs of trembling and shaking were observed in laboratory but not wild rabbits. Despite the high resistance of wild rabbits to
myxomatosis caused by South American strains of myxoma virus, the MSW strain was of such high virulence that it was able to overcome
resistance. The acute nature of the infection, relatively low viral titers in the tissues and destruction of lymphoid tissues, suggested that death was
probably due to an acute and overwhelming immunopathological response to the virus. No virus was found in the brain. The MSD strain was
attenuated compared to previously published descriptions and therefore was only characterized in laboratory rabbits. It is concluded that
Californian MSW strain of myxoma virus is at the extreme end of a continuum of myxoma virus virulence but that the basic pathophysiology of
the disease induced is not broadly different to other strains of myxoma virus.
Crown Copyright © 2005 Published by Elsevier Inc. All rights reserved.Keywords: Myxomatosis; Myxoma virus; Resistance; Pathogenesis; VirulenceIntroduction
Myxoma virus is a poxvirus (genus: Leporipoxvirus)
which causes the disease myxomatosis in the European rabbit
(Oryctolagus cuniculus). There are two broad geographic
types of myxoma virus, one found on the west coast of the
United States of America and the Baja peninsula of Mexico,
known as Californian myxoma virus and the other found in
South and Central America known as South American or Bra-
zilian myxoma virus. In South America, myxoma virus circu-
lates in the jungle rabbit or tapeti (Sylvilagus brasiliensis)
whereas Californian myxoma virus circulates in the brush rabbit⁎ Corresponding author. CSIRO Entomology, Clunies Ross Street, Acton,
ACT 2601, Australia.
E-mail address: peter.kerr@csiro.au (P.J. Kerr).
0042-6822/$ - see front matter. Crown Copyright © 2005 Published by Elsevier In
doi:10.1016/j.virol.2005.12.007(Sylvilagus bachmani). In their native hosts, the viruses induce a
cutaneous fibroma at the site of inoculation and are passively
transmitted on the mouth parts of mosquitoes and presumably
other biting arthropods. Both types of myxoma virus are capable
of infecting the European rabbit and cause the lethal dissemi-
nated disease myxomatosis (Fenner and Fantini, 1999).
Myxoma virus encodes an array of genes encoding proteins
which modulate the immune response of the infected host
(Cameron et al., 1999; Labudovic et al., 2004). Many of these
genes are essential for virulence in the European rabbit and
determine the outcome of infection and the pathogenesis of the
disease in this new host (Kerr and McFadden, 2002; Wang et
al., 2004).
Based on assays for 92 strains of myxoma virus, Fenner and
Marshall (1957) grouped viruses into five virulence grades
defined by mortality rate, average survival times (AST), andc. All rights reserved.
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intradermally with approximately 5 rabbit ID50. In this classi-
fication, Grade 1 viruses were 99.5% lethal with an AST ≤ 13
days, Grade 2 viruses were 99% lethal with an AST N 13 ≤ 16
days, Grade 3 viruses were 90% lethal with an AST N 16 ≤ 28
days, Grade 4 viruses were 60–70% lethal with an
AST N 28 ≤ 50 days, while Grade 5 viruses killed b30% of
infected rabbits. For grade 1 and 3 virus strains (the only types
tested), survival of rabbits was not altered over a dose range of
5 to 105 rabbit ID50 although the ASTwas reduced by around 2
days at the highest dose. The Californian MSW strain of myx-
oma virus was the most virulent described being of Grade 1
virulence with an AST of 9.2 days (Fenner and Marshall, 1957).
One of the characteristics of Californian strains of myxoma
virus is that laboratory rabbits die without showing classical
signs of myxomatosis (swollen eyelids, conjunctivitis, occulo-
nasal mucopurulent discharge, swollen anogenital region, swol-
len ears, large primary lesion, secondary lesions on ears, face,
and body, scrotal edema); those few rabbits that survive for
longer than 10 days or so develop classical myxomatosis (Fen-
ner and Marshall, 1957; Kessel et al., 1934). Based on the
observed clinical signs and the reported finding of some virus
in the brain of an infected rabbit (Fenner and Ratcliffe, 1965), it
was considered possible that the Californian strains of myxoma
virus were neurotropic or had a different pathogenesis to the
South American strains but this has not been determined.
One of the classic natural experiments in host-pathogen
coevolution was provided by the release of myxoma virus in
Australia in 1950 as a biological control for the European
rabbit. A South American strain of myxoma virus (Standard
Laboratory Strain; SLS) of grade 1 virulence was successfully
introduced into the Australian wild European rabbit population
in 1950. These rabbits were completely naive to myxoma virus
and, unlike in the Americas, there were no animal reservoirs for
the virus other than O. cuniculus. This meant that the virus was
strongly selected for transmission from the previously acciden-
tal host O. cuniculus. Over the next 50 years, a complex
coevolution of host and virus has occurred. This was initially
characterized by the emergence of attenuated strains of virus
which were more effectively transmitted by mosquitoes be-
cause the infected rabbits survived longer (Fenner et al.,
1956). At the same time, the rabbits were selected for resistance
to myxoma virus (Marshall and Fenner, 1958; Fenner, 1983;
Fenner and Fantini, 1999). Wild rabbits are now strongly resis-
tant to SLS (Best and Kerr, 2000; Kerr et al., 2004). Recent
testing showed only 20% mortality in wild rabbits infected with
SLS compared with 100% mortality of SLS-infected laboratory
rabbits (AST of 11.3 days) (Kerr et al., 2004; Robinson et al.,
1999).
The genetic basis of resistance to myxomatosis in Australian
wild rabbits has not been determined. However, detailed path-
ogenesis studies have shown that the outcome of infection in
resistant wild rabbits depends on both the resistance of the
rabbit and the virulence of the virus (Best and Kerr, 2000;
Kerr et al., 2004). Highly virulent strains of myxoma virus
such as the Lausanne strain (Brazil/Campinas/1949) which is
a Grade 1 virus with an AST of 10.7 (Jackson et al., 1996) to12.9 days (Fenner and Marshall, 1957) in laboratory rabbits, or
a recombinant SLS expressing rabbit IL-4 are able to overcome
resistance in wild rabbits (Kerr et al., 2003, 2004).
To determine whether the Californian strains of myxoma virus
were neurotropic and to further characterize genetic resistance to
myxoma virus in Australian wild rabbits, this paper examines the
virulence and pathogenesis of the type strain of Californian
myxoma virus (MSW) in resistant and susceptible European
rabbits. As a comparison, we also examined another Californian
myxoma virus strain, the MSD strain. Although originally de-
scribed as having Grade 1 virulence (Fenner and Marshall,
1957), the MSD strain we tested proved to be attenuated.
Results
Characterization of MSW
Virulence of MSW
Infection with MSW caused 100% mortality in both suscep-
tible (laboratory) rabbits and resistant (wild) rabbits. For labo-
ratory rabbits, the mean survival time was 7.3 days (SD 0.82;
range 6.5–8.5 days) and for wild rabbits the mean survival time
was 9.4 days (SD 2.90; range 6.5–14.5 days). This difference
was not statistically significant (Student's t test assuming un-
equal variances, P N 0.05). The mean survival time for labora-
tory rabbits infected with MSW has previously been reported as
9.2 days with a range of 7–14 days (Fenner andMarshall, 1957).
Clinical signs of infection with MSW
The clinical signs of infection of laboratory and wild
rabbits with MSW are summarized in Table 1. The key fea-
tures were the development of a primary lesion in the skin at
the inoculation site and the development of very mild clinical
signs of myxomatosis such as swelling of the eyelids and ano-
genital regions. Difficulties with coordination and balance
were noted for the laboratory but not the wild rabbits. In the
day prior to death, laboratory rabbits were observed in sternal
recumbency, panting, with wet fur on the chest and front feet
and occasional violent trembling. The wild rabbits were de-
pressed with labored breathing prior to death but did not have
the same wetness of fur and the trembling was not observed.
Only one rabbit developed the mucopurulent occulo-nasal
discharge typical of classical myxomatosis and this was the
wild rabbit that survived to day 14. The normal rectal temper-
ature range in laboratory rabbits is from 38.5° to 40° (Hark-
ness and Wagner, 1989). In rabbits infected with myxoma
virus, we regard rectal temperatures ≥40° as elevated and
≤38° as indicating a poor prognosis (Best and Kerr, 2000).
The temperature response to infection was quite inconsistent
with both elevated temperatures and depressed temperatures
prior to death; in the three wild rabbits with the longest
survival times, the rectal temperature was dropping in the
days prior to death (Fig. 1).
Pathogenesis of MSW in laboratory and wild rabbits
The pathogenesis of MSW was examined by injecting
rabbits with 1000 pfu into the skin on the dorsal surface of
Fig. 1. Rectal temperatures of laboratory (susceptible) (A) and wild (resistant)
(B) rabbits infected with 1000 pfu of MSW.
Table 1
Clinical signs of infection with MSW in rabbits
Days post-
infection
Laboratory rabbits Wild rabbits
2 Primary lesion dark pink, soft,
raised 0.4 cm, 1 × 1.5 cm
Thickening at inoculation site,
pale pink 1 × 1 cm
4 Primary lesion hardened,
2.5 × 2.5 cm, dark pink,
raised 0.5 cm, one of nine
rabbits had inflamed eyelids
Thickened lesion, 1.5 × 2 cm,
not raised, rosy pink
6 Primary lesion dark pink,
hardened, round, 3 × 2.5 cm,
raised 0.5 cm, inflamed eyelids,
one of six had ano-genital
swelling
Lesions as at 4dpi, darker pink
in color, slightly inflamed
eyelids on all rabbits
Days 7–8 Rabbits depressed, loss
of balance and coordination,
rapid respiration, primary lesion
raised 0.5 cm, 4 × 3 cm,
softened hemorrhagic patches
across the surface (pale with
black/purple flecks), moderate
ano-genital swelling and
inflamed eyelids, nose and ears.
Only one rabbit survived to
day 8.
Primary lesion thick and
hardening, not raised, dark
pink, 2 × 2 cm, inflamed
eyelids, base of ears swollen,
ano-genital swelling present
in one of four rabbits
10 No samples Primary lesion 2.5 × 2.5 cm,
turgid, dark pink, inflamed
eyelids, ears and ano-genital
regions on all rabbits
74 L. Silvers et al. / Virology 348 (2006) 72–83the hind foot. This means that virus first drains to the
popliteal lymph node on that leg (Best and Kerr, 2000).
Dissemination to other tissues then occurs from this site.
This enables viral replication and dissemination to be exam-
ined in a stepwise fashion. Viral titers were measured in
tissues collected from the inoculation site, popliteal lymph
node draining the inoculation site, skin on the opposite hind
foot (distal skin), the contralateral popliteal lymph node,
spleen, lung, kidney, liver, and brain; testis, thymus, and
eyelid were measured for laboratory rabbits only. Titers of
virus for the skin, lymphoid tissues, and lung are shown in
Fig. 2. A progression of infection can be seen with virus
initially present in the skin at the inoculation site of both
laboratory and wild rabbits 48 h after infection (Fig. 2A). At
this time, virus was also detected in the draining lymph node
of laboratory but not wild rabbits (Fig. 2B). By 4 days after
infection, virus was present in the contralateral lymph nodes
of laboratory rabbits (Fig. 2C) and the spleens of both groups
(Fig. 2D). MSW was present in the distal skin and eyelids of
laboratory rabbits by day 6 but at this stage was not detected
in distal skin of wild rabbits (Fig. 2E). The peak virus titers
in skin were 10–100-fold lower in wild rabbits compared to
laboratory rabbits for both the inoculation site and distal skin.
Low titers of virus were present in the lungs of some rabbits
(Fig. 2F) and similar titers (103–104 TCID50/g) were present
in the liver, kidneys, and testes of laboratory rabbits at day 7
and 8 but no virus was detected in these tissues in wild
rabbits. Virus was not detected in the brain or thymus at
any time point.Histopathology and immunohistology of MSW infection
Hematoxylin and eosin stained sections of skin, draining
lymph node, contralateral lymph node and spleen were exam-
ined at each time point for the laboratory and wild rabbits
infected with MSW. The results are summarized and compared
in Table 2.
The pathology in the skin at the inoculation site was char-
acterized by proliferation of the epidermal cells and subsequent
degeneration of these cells with very little inflammatory cell
response in the underlying dermis. The major changes in the
dermis were disruption of the collagen by fluid accumulation,
fibrin deposition, and infiltration of large macrophage-like
cells, which appeared to be migrating from the walls of small
blood vessels.
The staining and distribution of virus-infected cells in the
skin at the inoculation site were very similar for wild rabbits
and laboratory rabbits. At day 2, virus-infected cells, predom-
inantly elongated macrophages, and also some rounded cells
resembling lymphocytes, were scattered through the dermis
often in clusters adjacent to the blood vessels (Fig. 3A). By
day 4, there were also positively stained cells in the hair
follicles and occasional patches of surface epidermis (Fig.
3B). Fig. 3C shows proliferation of epidermal cells and bal-
looning degeneration of the infected cells from a wild rabbit at
day 10. Sections were also stained for CD43 to demonstrate T
lymphocytes. CD43-positively stained cells were scattered
throughout the upper dermis at day 2 (Fig. 3D) but were less
common at day 4 (Fig. 3E) and at later time-points. In addition,
those cells present at later time points often appeared to be
degenerating. Wild rabbits had a similar distribution of CD43-
positive cells in the skin to laboratory rabbits.
Fig. 2. Virus titers in tissues of laboratory (susceptible) and wild (resistant) rabbits infected with 1000 pfu of MSW. Scatter plots indicate titers for each laboratory
rabbit □ and wild rabbit ○ in each tissue.
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lymphocytes in the laboratory rabbits by day 4. This was asso-
ciated with a large amount of apoptotic and necrotic debris. The
underlying cells remained largely intact although the cytoplasm
became very vacuolated giving a foamy appearance. This loss of
lymphocytes also occurred in the wild rabbits although the
nodes were not completely depopulated until day 6. Infiltration
of the nodes with polymorphonuclear cells (PMNs) was much
more common in the wild rabbits than in the laboratory rabbits.
In most lymph node sections, and at all time points, there were
very few infected cells. Some lymphocytes in the draining
lymph node of laboratory rabbits stained weakly for virus at
day 2 and sections from one rabbit had large numbers of infected
cells at day 4 (Fig. 3F). The destruction and cell death surround-
ing virus-infected cells in the remains of the lymph node cortex
are shown at higher magnification in Fig. 3G. At day 6, there
were virtually no lymphocytes remaining in the nodes but some
cells were positive for virus (Fig. 3H). In wild rabbits, there was
similar scattered positive staining in the draining lymph node at
day 4 but by day 6 most lymphocytes were depleted from thenodes and only the occasional virus-infected cell or cluster of
infected cells could be found.
The distal lymph nodes of laboratory rabbits had similar
pathology to the draining nodes at day 4 although only a few
cells were positive for virus; distal nodes were almost com-
pletely devoid of lymphocytes by day 6. Virus-infected cells
were more common at day 6 in the distal nodes but by days 7
and 8 there were only occasional positive cells. Fig. 3I shows
clusters of infected cells and generalized lymphocyte loss in a
distal lymph node from a laboratory rabbit at day 6. The loss of
lymphocytes in the distal nodes of wild rabbits was less con-
sistent although still a prominent feature of infection with
MSW. Virus-infected cells were uncommon in the wild rabbit
distal nodes but occasional clusters of positively stained cells
were present from day 6 through to day 10.
The difference in lymphocyte depletion between wild and lab-
oratory rabbits was particularly noticeable in the spleens. Labora-
tory rabbits had complete loss of lymphocytes from the spleen
white pulp areas by day 4 whereas these areas remained populated
with lymphocytes throughout the infection in wild rabbits.
Table 2
Histopathology of MSW infection
Time Laboratory rabbits Wild rabbits
Day 2 Skin: Patches of inflammation deep in the dermis;
occasional PMN; lot of macrophages;
cells budding from blood vessels.
Skin: Some disruption of collagen in patches directly
under the epidermis. Patches of necrotic mononuclear cells.
dLN: Some swelling of capsule and trabeculae with
occasional PMN. Nodes well populated with
lymphocytes with good definition of follicles and
some germinal centers.
dLN: Trabeculae and sinuses appear swollen.
Lot of PMNs in one node. Well populated
with lymphocytes and good definition of follicles.
cLN: Nodes well populated with lymphocytes with
good follicle definition and active germinal centers.
cLN: Nodes are well populated with lymphocytes.
Some swelling and fluid accumulation.
Spleen: Well defined white pulp areas around the
arterioles. Lymphocytes scattered through red pulp.
Spleen: Well defined red and white pulp areas.
Day 4 Skin: Epidermal cell proliferation and degeneration;
collagen disruption; necrotic PMNs and fibrin
deposition in dermis.
Skin: Epidermal cell proliferation and degeneration;
collagen structure disrupted with fluid and fibrin
deposition. Large numbers of macrophages and
occasional PMNs in lower dermis.
dLN: Almost completely depopulated of
lymphocytes. Remaining lymphocytes have dark
pyknotic nuclei.
dLN: Large amount of lymphocyte loss has occurred
but not as severe as laboratory rabbits. Nodes are
swollen with a lot of PMN infiltration and free rbc.
cLN: Nodes almost completely depopulated of lymphocytes.
Many apoptotic cells. Some patches of lymphocytes
present in paracortex.
cLN: Nodes are well populated with lymphocytes
with well defined follicles. Patches of PMN infiltration.
Spleen: PALS completely depopulated of lymphocytes.
In some cases, lymphocytes still present in red pulp.
Spleen: PALS and follicles well populated with lymphocytes.
Red pulp appears engorged with rbc and few lymphocytes;
lot of PMNs in red pulp.
Day 6 Skin: Epidermal cell proliferation and degeneration.
Disruption of collagen in upper dermis. Deep in the dermis,
there are a lot of necrotic macrophages/fibroblasts with collagen
disruption and fibrin deposition.
Skin: Patchy epidermal cell proliferation and degeneration;
underlying collagen is disrupted with fibrin deposition and
occasional mononuclear cells.
dLN: Completely depopulated of lymphocytes. dLN: Nodes are almost completely depopulated of lymphocytes.
cLN: Nodes are completely or almost completely devoid of
lymphocytes.
cLN: Two of three nodes were largely devoid of lymphocytes,
one node was well populated with lymphocytes.
Spleen: PALS devoid of lymphocytes. Lymphocytes in
red pulp appear apoptotic/pyknotic.
Spleen: PALS are well populated with lymphocytes.
Cell death and inflammation in red pulp.
Day 7/8 Skin: Epidermal cell proliferation. Disruption of collagen
in dermis with necrotic cells and macrophages threaded
through the remaining collagen fibers.
Skin: Epidermal cell proliferation and degeneration with
collagen disruption and fibrin deposition in the dermis.
Very little cellular response in upper dermis but a lot of
degenerate macrophage-like cells in lower dermis.
dLN: Completely devoid of lymphocytes at day 7;
lot of empty space and fibrin deposition. The one day 8
node appeared to have some resolution with cells
migrating into periphery of node.
dLN: Nodes completely devoid of lymphocytes,
patches of fibrin and apoptotic debris still present.
cLN: Completely devoid of lymphocytes with a lot of
necrotic/apoptotic debris. Some resolution and immigration
of cells at day 8.
cLN: Nodes from 2 rabbits were largely depopulated
with a lot of necrotic/apoptotic debris but one rabbit
had a well populated node.
Spleen: At day 7, there are no lymphocytes in the white
pulp areas. However, at day 8 there are some lymphocytes
immigrating into the PALS.
Spleen: Well populated PALS or partially depopulated.
Lot of lymphocytes in red pulp areas.
Day 10 Skin: Epidermal cell proliferation in patches.
Upper dermis appears more cellular but most cells appear
degenerate/necrotic. Some new collagen deposition in
lower dermis.
dLN: Immigration of lymphocytes in some sections.
cLN. Ranged from well populated with lymphocytes to
almost completed depopulated with cells migrating in.
Spleen: Very well populated PALS
Abbreviations: dLN: draining lymph node; cLN contralateral lymph node; PMN: polymorphonuclear cell; PALS: periarteriolar lymphoid sheaths.
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of the pathology in the lymph nodes and a small number of
CD43-positive lymphocytes were migrating into the periphery
of the nodes in both laboratory and wild rabbits (data not
shown).Replication of MSW in rabbit lymphocytes
Because of the very low titers of MSW in lymph nodes and
the low number of cells staining for virus, the rabbit T lympho-
cyte cell line RL-5 was used to investigate replication of MSW
in rabbit lymphocytes. Fig. 4 shows that MSW replicated in
Fig. 3. Immunohistopathology of MSW infections. (A) Skin at inoculation site 2 days after infection: immunoperoxidase detection of virus-infected cells which are
stained brown. Arrows indicate examples of infected cells in dermis (high power magnification (HP):original magnification ×400). (B) Skin at inoculation site 4 days
after infection: immunoperoxidase detection of virus-infected cells. Arrows indicate examples of infected cells in epidermis (HP). (C) Skin at inoculation site 10 days
after infection: immunoperoxidase detection of virus-infected cells in epidermis (arrowed) (HP). (D) Skin at inoculation site 2 days after infection: immunoperoxidase
detection of T lymphocytes. Examples are indicated by arrows (medium power magnification (MP): original magnification ×200). (E) Skin at inoculation site at 4
days after infection: immunoperoxidase detection of T lymphocytes. Examples are indicated by arrows; note increased thickness of epidermis compared to day 2
indicating viral-induced proliferation (MP). (F) Draining lymph node of laboratory rabbit 4 days after infection: immunoperoxidase detection of virus-infected cells
(low power magnification (LP): original magnification ×100). (G) Draining lymph node of laboratory rabbit 4 days after infection: immunoperoxidase detection of
virus-infected cells HP view of panel F, arrows indicate examples of apoptotic cells. (H) Draining lymph node of laboratory rabbit 6 days after infection:
immunoperoxidase detection of virus-infected cells. Arrow indicates infected cell (HP). (I) Distal lymph node of laboratory rabbit 6 days after infection:
immunoperoxidase detection of virus infected cells. Arrows indicate clusters of infected cells (LP).
Fig. 4. Replication kinetics of MSW in RL-5 cells. Log10 virus titers at MOI of
0.1 -□- and 0.01 -○-. Insert: immunofluorescent image demonstrating virus
antigen (white) in RL-5 cells.
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virus and the titers of virus.
Serum antibody titers to myxoma virus following infection with
MSW
Antibodies against MSW could not be detected using
ELISA in serum from laboratory rabbits prior to death. Very
low titers of antibodies were detected in sera from wild rabbits
just prior to death at 8 and 10 days post-infection (1:100 and
1:800, respectively).
Characterization of MSD
Virulence of MSD
In contrast to MSW, infection of laboratory rabbits with
MSD killed only one of six rabbits with a survival time of
11.5 days. The remaining five were still alive, albeit with
clinically severe myxomatosis, at day 18 and were euthanized
at this time. Laboratory rabbits infected with MSD have previ-
ously been reported as having a mean survival time of 12.6
Fig. 5. Rectal temperatures of laboratory rabbits infected with 1000 pfu of
MSD.
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Based on this, the stock of MSD was attenuated, particularly
compared to MSW. Because of this attenuation, virulence tests
of MSD were not performed in resistant rabbits.
Clinical signs of infection with MSD
The skin at the inoculation site was red and swollen by 2
days after injection of MSD. This primary lesion increased in
size to approximately 2 × 3 cm at day 7 after infection. At this
time, the eyelids were also beginning to swell. By day 11, there
was severe inflammation and swelling of nose, eyelids, ears,
and ano-genital areas; secondary lesions were present at the
base of the ears and there was mucopurulent discharge from the
conjunctivae. These clinical signs increased in severity with the
rabbits becoming progressively more depressed; mucopurulent
discharge glued the eyelids together and obstructed the nostrils.Fig. 6. Virus titers in tissues of laboratory rabbits infected with 1000 pfu of MSD
inoculation site; □ distal skin. (B) ○ Draining lymph node; □ distal lymph node. (By day 15, all rabbits had difficulty breathing. Buprenorphine
was administered daily as an analgesic at this stage and the
rabbits were euthanized at day 18. Rectal temperatures of
MSD-infected rabbits increased between days 4 and 6, which
is similar to the wild rabbit MSW infections. By the last few
days of the trial, the temperatures were largely within the
normal range as shown in Fig. 5. These clinical signs of
myxomatosis resemble those of moderately attenuated South
American virus strains of myxoma virus (Best and Kerr, 2000).
Restriction endonuclease analysis of DNA from MSD
Because MSD had previously been reported to be highly
lethal (Fenner and Marshall, 1957), we wished to confirm that
the virus we tested was a Californian strain of myxoma virus.
Viral DNAwas prepared and digested with the restriction endo-
nuclease EcoRI. Gel electrophoresis of the resulting DNA frag-
ments demonstrated that the virus stock was of a Californian
strain with the same EcoRI digestion profile as MSW (Labudo-
vic et al., 2004) but with no shared fragments with South
American strains of myxoma virus (data not shown).
Pathogenesis of MSD in laboratory rabbits
The pathogenesis of MSD was examined in laboratory
rabbits in the same manner as MSW except that virus titers
were only measured at days 4, 6, and 10 after infection. The
virus titers in the skin, lymphoid tissues, spleen, lung, liver, and
testis are shown in Fig. 6. Similarly to MSW, there is a stepwise
progression with high titers of virus present in the inoculation
site and draining lymph nodes at day 4. Virus is also present in
spleen and contralateral lymph nodes at this time and was. Scatter plots show individual rabbit titers at each time point. (A) ○ Skin at
C) ○ Spleen; □ lung. (D) ○ Liver; □ testis.
Table 3
Histopathology of MSD infection
Time Laboratory rabbits infected with MSD
Day 4 Skin: Patchy proliferation of epidermal cells; some mononuclear cells
in upper dermis; collagen appears intact but with some spaces between
fibers; a few large cells migrating from the walls of the small blood
vessels.
dLN: Greatly reduced numbers of lymphocytes, complete loss of
lymphocytes in some sections of nodes with necrosis/apoptosis, PMN
infiltration; loss of follicles.
cLN: Architecture of nodes intact; swollen sinuses and trabeculae;
patchy loss of lymphocytes.
Spleen: PALS are well defined and populated with lymphocytes; some
patches of PMN infiltration in red pulp.
Day 6 Skin: Collagen fibers in upper and lower dermis disrupted with fluid
accumulation and fibrin deposition; rbc and mononuclear cells in upper
dermis; patches of proliferation and degeneration of epidermis; small
blood vessels are very prominent in upper dermis.
dLN: Ranged from reasonably well populated node to almost totally
devoid of lymphocytes.
cLN: Swollen with follicles pushed to periphery; some areas of
lymphocyte depopulation.
Spleen: Ranged from well populated PALS and follicles with germinal
centers to some loss of lymphocytes around the arterioles. Regions of
apoptosis in red pulp.
Day
10
Skin: Epidermal cell proliferation and degeneration; collagen
disruption and fibrin deposition but also patches of new collagen
being deposited; cell proliferation from blood vessel walls.
dLN: Ranged from node almost devoid of lymphocytes to very swollen
node well populated with lymphocytes but some areas of depopulation.
cLN: Swollen nodes with follicles pushed to periphery. One node was
partially depopulated but lymphocytes appeared to be repopulating this
node.
Spleen: Very prominent PALS with fainter staining halo of
lymphocytes around these. Red pulp was almost obscured by
lymphocytes in one spleen. In all cases, the red pulp contained a lot
of PMNs.
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virus were found in spleen and contralateral lymph nodes as
well as distal skin. Virus was also present in testis, lung, liver,
and thymus. However, by day 10, virus titers had decreased
suggesting that the immune system was beginning to clear the
virus. Virus was not detected in the brain at any time-point.
Histopathology and immunohistology of laboratory rabbits
infected with MSD
The histopathology of laboratory rabbits infected with MSD
is summarized in Table 3. In the skin at the inoculation site, the
pathology of MSD was broadly similar to MSW. Virus was
present in cells of the dermis at day 4 and in the occasional
epidermal cell (Fig. 7A). At day 6, virus was still mainly in
macrophages of the dermis and in elongate cells immediately
below the epidermis but virus was also present in the epidermal
cells, chiefly within the hair follicles. Fig. 7B shows virus
staining in epidermal cells at day 10.
The limited numbers of inflammatory cells present were
predominantly macrophages with a few PMNs, lymphocytes,
and monocytes. Staining for CD43 showed scattered T cells in
the upper dermis at day 4, generally within blood vessels but
also migrating out of these. At day 6, there were far fewer
CD43-positive cells and those that were present appeared ne-crotic. Similarly, at day 10, CD43-positive cells were uncom-
mon outside the blood vessels (data not shown).
Lymphocytes and macrophage-like cells in the draining
lymph nodes stained positively for virus at day 4; some regions
were packed with virus-infected cells (Fig. 7C). At higher
magnification, many apoptotic and necrotic cells can be seen
surrounding the infected cells (Fig. 7D). At day 6, the nodes
varied from well-populated with lymphocytes to depleted para-
cortical regions with scattered positive staining for virus. Sim-
ilarly to day 6, at day 10, there was a range of pathology from
massive depopulation of lymphocytes to well-populated nodes.
Destruction of the follicles was common. Fig. 7E shows pa-
thology at day 10 with virus-infected cells still present. In
general, there was much more virus staining in the draining
lymph nodes of rabbits infected with MSD than rabbits infected
with MSW.
Cells infected with virus were uncommon in the contralateral
lymph node and spleen but could be found from day 4 (Fig. 7F).
Serum antibody to myxoma virus in rabbits infected with MSD
Serum antibody was detectable at very low levels at 6 dpi
(1:100), increasing to 1:200 and 1:400 at 10 dpi. By day 18,
antibody titers ranged between 1:6400 and 1:25,600.
Discussion
The aims of this work were to determine whether the Cali-
fornian strains of myxoma virus were neurotropic and to ex-
amine whether these viruses could overcome genetic resistance
to myxoma virus in wild rabbits. As previously demonstrated
by Fenner and Marshall (1957), the MSW strain of myxoma
virus was of Grade 1 virulence in laboratory rabbits. This is
comparable to the virulence of the SLS originally released in
Australia; however, the average survival time of rabbits
infected with MSW is less than that for SLS indicating that it
is of higher innate virulence. Australian wild rabbits have
developed strong resistance to SLS—in recent testing, four of
five infected wild rabbits recovered from infection while the
fifth was euthanized on day 19 because of pneumonia (Kerr et
al., 2004). Infection with MSW completely overcame this re-
sistance in wild rabbits. This supports previous studies that
have demonstrated that resistance to myxomatosis in Australian
wild rabbits is quantitative and that the outcome of infection
depends on both the resistance of the host and the virulence of
the virus (Kerr et al., 2003; Best and Kerr, 2000; Kerr et al.,
2004).
As has been previously reported (Fenner and Marshall,
1957), the rabbits infected with MSW did not develop classical
myxomatosis except in one rabbit where survival time was
extended. Laboratory rabbits in particular developed some
signs of central nervous system dysfunction such as muscle
twitching, hypersensitivity to stimulation, depression, and
coma. The classical clinical signs of myxomatosis, swollen
eyelids, ears, noses, and heads, together with mucopurulent
discharge from the eyes and nose, were absent. Moreover,
infection with MSW was not associated with high titers of
virus in any tissue. In particular, virus was not detected in the
Fig. 7. Immunohistopathology of MSD infections. (A) Skin at inoculation site 4 days after infection: immunoperoxidase detection of virus-infected cells which are
stained brown. Long arrow indicates cluster of infected cells in dermis; short arrows indicate examples of infected elongate cells (LP). (B) Skin at inoculation site 10
days after infection: immunoperoxidase detection of virus-infected cells. Long arrows indicate examples of infected epidermal cells; short arrows indicate examples of
infected cells deep in the dermis (LP). (C) Draining lymph node 4 days after infection: immunoperoxidase detection of virus-infected cells (LP). (D) Draining lymph
node from C (HP). Arrows indicate examples of apoptotic cells. (E) Draining lymph node 10 days after infection: immunoperoxidase detection of virus-infected cells
(examples arrowed) (HP). (F) Distal lymph node 6 days after infection: immunoperoxidase detection of virus-infected cells (arrow) (MP).
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nervous system dysfunction are not due to replication in the
brain by MSW but are more likely associated with metabolic
dysfunction induced by the host response to infection.
The titers of virus following MSW infection in these patho-
genesis trials were much lower than found in acute infections
with South American strains of virus such as SLS, where titers
in the skin or draining lymph nodes are N107 pfu/g (Best and
Kerr, 2000), or than the limited information previously reported
for MSW (Fenner and Marshall, 1957). This was particularly
the case in the lymph nodes. In general, there were very few
virus-infected cells present in the lymph nodes. The underlying
cells of the node were not infected with virus. However, these
low titers were not a consequence of MSW being unable to
replicate in rabbit lymphocytes as was demonstrated by the
rapid replication of the virus in the rabbit T lymphocyte cell
line RL-5.
The histopathology following infection with MSW was gen-
erally similar to the detailed descriptions for South American
myxoma virus provided by Rivers (1930) and Hurst (1937) and
for Californian myxoma virus by Kessel et al. (1934). MSW
infection induced acute pathology in the draining and contra-
lateral lymph nodes with rapid loss of lymphocytes from these
tissues and from the spleens of laboratory rabbits. The wild
rabbits showed some evidence of resistance to these effects;
depletion of lymphocytes from the draining lymph nodes was
slower in wild rabbits and did not occur as completely in the
distal lymph nodes. In contrast to laboratory rabbits, there was
no depletion of lymphocytes from the spleens of wild rabbits.
In both types of rabbit, there was some resolution of the
pathology in the lymphoid tissue at late time points with limited
migration of lymphocytes occurring into the cortex of the
nodes. This suggested that the initial destructive conditionswere capable of being resolved if the animal could survive the
acute phase of the infection.
The MSD strain of myxoma virus provided an unexpected
contrast to the virulence of the MSW strain. Rabbits infected
with MSD developed classical myxomatosis and did not show
signs of central nervous system dysfunction. Moreover, the
titers of virus in the inoculation site and draining lymph
nodes of infected rabbits were 10–100-fold higher than those
of MSW-infected rabbits. These higher titers of MSD in the
lymph node were in agreement with the ready detection of virus
in the nodes by immunostaining. In addition, the depletion of
lymphocytes from the nodes was slower in MSD infection
compared to MSW and the splenic white pulp areas remained
well populated with lymphocytes in laboratory rabbits as well
as wild rabbits.
The cause of death in myxomatosis has never been satisfac-
torily determined (Hobbs, 1928; Kerr and McFadden, 2002;
Mims, 1964). As shown here, the virus is able to infect lym-
phoid cells such as macrophages and lymphocytes. Like other
poxviruses, myxoma virus encodes proteins that suppress anti-
viral immune responses by cytokines such as TNF-α, type 1
and type 2 interferons, and CC chemokines. Expression of
MHC-1, FAS, and CD4 molecules is downregulated in infected
cells and at least four myxoma virus encoded proteins are
involved in inhibiting apoptosis in infected lymphocytes (Kerr
and McFadden, 2002).
Septic-shock models induced by inflammatory cytokines
and chemokines have been proposed to explain coma and
death in acute bacterial infections, protozoal infections, and
some acute virus infections including poxviruses (Bray and
Mahanty, 2003; Clark et al., 2004; Rubins et al., 2004). The
clinical and pathological similarities between these syndromes
and infection with MSW, together with the lack of alternative
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rabbits, death was due to an overwhelming response by inflam-
matory mediators to virus or virus-induced tissue damage. The
slower and more limited lymphocyte destruction in MSD-
infected rabbits and in wild rabbits infected with MSW sug-
gests that this lymphocyte death is a marker of induction of
inflammatory and metabolic pathways that are critical in both
pathogenesis of myxoma virus and that are potentially regulat-
ed in genetic resistance to myxomatosis.
While MSW is more virulent than previously described
South American strains of myxoma virus, it did not induce
any novel pathological features, nor was virus found in the
brain. This suggests that virulence of myxoma virus can be
thought of as a continuum that has an overwhelming response
and acute death at one end and immune suppression with
chronic secondary bacterial infection and prolonged survival or
recovery at the other end. The reason for the high virulence of the
MSW strain has not been determined but preliminary sequencing
studies have demonstrated that three of the known virulence
genes (M151R, M152R, M153R) and a potential virulence
gene (M156R) are duplicated compared to the fully sequenced,
Grade 1 virulent, South American “Lausanne” strain (Labudovic
et al., 2004; Cameron et al., 1999). Lausanne was lethal in wild
rabbits but the infected rabbits had prolonged survival times
ranging from 14 to 100 days (Kerr et al., 2003) which were
much longer than the survival times of wild rabbits infected with
MSW. It is possible that the duplication of these genes may
provide an explanation for the high virulence of MSW.
Methods
Rabbit breeding and housing
All rabbit experiments were conducted under the guidance
of the National Health and Medical Research Council/CSIRO
guidelines; protocols were approved by the CSIRO Sustainable
Ecosystems Animal Experimentation Ethics Committee.
Laboratory and wild rabbits were bred in the Gungahlin
animal facility of CSIRO Sustainable Ecosystems. Experimen-
tal animals were over 4 months old, housed in individual cages
under controlled temperature (20 °C) and light (12 h/12 h)
regimes. Animals had ad libitum access to water and standard
rabbit pellets and were fed fresh greens once per week.
Viruses
Myxoma virus strain MSW (USA/San Francisco/1950/1) is
designated as the prototype strain of Californian myxoma virus
(Fenner and Marshall, 1957). Virus stock was prepared from a
freeze dried rabbit tissue extract originally prepared 14/02/1956.
Myxoma virus strain MSD (USA/San Diego/1949/1) was pre-
pared from a freeze dried rabbit tissue extract originally prepared
16/03/1955. The original stocks were obtained from Professor
Frank Fenner, John Curtin School of Medical Research, Austra-
lian National University, Canberra, ACT, Australia.
Working stocks of each virus were prepared by intradermal
inoculation of a male rabbit with each virus. Eight days afterinfection, the rabbits were killed with an intravenous overdose
of pentobarbitone and the testes removed using sterile tech-
nique. The surrounding membranes were removed and each
testis was minced with scissors and then homogenized through
a 10 ml syringe into 5 ml of phosphate buffered saline (PBS,
pH 7.4). After freeze thawing at −70 °C, the homogenates were
sonicated (3 × 5 s at maximum output on ice) using a probe
sonicator, centrifuged (230 g × 20 min) at 0 °C, and the super-
natants removed, aliquoted, and stored at −70 °C. Titers were
determined by plaque assay on Vero cell monolayers.
Cell lines and culture conditions
RK13 and Vero cells were maintained in minimal essential
medium supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, 200 units/ml penicillin, and 100 μg/ml streptomycin
(MEM). RL-5 cells were maintained in RPMI plus 10% fetal
bovine serum 2 mM L-glutamine, 200 units/ml penicillin, and
100 μg/ml streptomycin.
All cells were grown at 37 °C in an atmosphere of 5% CO2/
95% air.
Virulence assays
Virulence was determined by infection of six male rabbits
over 6 months old. Each rabbit was inoculated with 1000
plaque forming units (pfu) intradermally in the left flank.
Rabbits were checked twice daily; rectal temperatures were
measured and clinical signs recorded each morning. The opioid
analgesic buprenorphine HCl (Temgesic, 0.03 mg/kg; subcuta-
neously; Schering-Plough) was administered to rabbits after
day 8 (Robinson et al., 1999). Survival times were estimated
to the nearest 0.5 day.
Pathogenesis experiments
Rabbits were randomly allocated to sampling days at the
beginning of each experiment. For MSW pathogenesis, trials
were done in both wild and laboratory rabbits but for MSD
trials were only done in laboratory rabbits. Rabbits were mon-
itored daily, rectal temperatures and clinical signs were
recorded, and blood samples collected every second day. At
each time-point, three rabbits were euthanized with an intrave-
nous overdose of pentobarbitone. For MSW infections of lab-
oratory rabbits, the times were 2, 4, 6, 7, and 8 days after
infection but only one rabbit survived to day 8. Therefore,
results for day 8 are from a single animal. For MSW infections
of wild rabbits, the times used were 2, 4, 6, 8, and 10 days after
infection. For laboratory rabbits infected with MSD, the times
used were 4, 6, and 10 days. At autopsy, tissues were collected
for virus detection onto dry ice and into 4% formaldehyde in
PBS (ph 7.2) for histology and immunohistochemistry.
Virus titrations
Tissue samples were processed as described in Best and Kerr
(2000). MSW titers were assayed by the TCID50 method in
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Briefly, 50 μl of serially diluted virus was added to each well in
sextuplicate and the plates incubated for 60 min at 37 °C, 5%
CO2/95% air, 150 MEM was then added to each well, and the
plates incubated for 7 days at 37 °C, 5% CO2/95% air. Each well
was scored as positive or negative for cytopathic effect (cpe)
under 10× objective magnification. Titers were expressed as
TCID50 per gram of tissue using the method of Reed and
Muench (1938). MSD was titrated by plaque assay on Vero
cell monolayers as previously described (Best and Kerr, 2000).
Histology
Samples for histopathology were embedded in paraffin,
sectioned at 4 μm, and stained with hemotoxylin and eosin.
For immunohistology, 4 μm sections were placed in duplicate
on poly-L-lysine coated slides. Following removal of paraffin
by immersion in xylene for 10 min, sections were rehydrated
through an alcohol gradient by immersion in 100% alcohol
(90% ethanol, 5% methanol, 5% isopropanol by volume) for 2
min, 95% alcohol (85.5% ethanol, 4.75% methanol, 4.75%
isopropanol, 5% water by volume) for 4 min, and finally, 80%
alcohol (72% ethanol, 4% methanol, 4% isopropanol, 20%
water by volume) for 4 min. Antigen retrieval was performed
by immersion in 0.01 M citrate buffer (pH 6.0) in a 95 °C
water bath for 20 min then cooling to room temperature for
20 min while still immersed in buffer. Sections were circled
using a cytomation pen (Dako) to ensure that sections would
be completely covered by solution during subsequent incuba-
tions. Peroxidase quenching was performed by incubation in
sodium azide peroxidase blocking reagent (Dako) for 5 min at
room temperature. For detection of myxoma virus, sections
were treated with 1:1000 dilution of the anti-myxoma virus
monoclonal antibody 3B6E4 (Fountain et al., 1997) at room
temperature for 60 min. To stain T lymphocytes, sections
were incubated with 1:100 mouse-anti-rabbit CD43 (clone
L11/135; Wilkinson et al., 1992; Serotec) at room temperature
for 4 h. Primary antibody incubation was followed by wash-
ing in 0.5% v/v Tween 20 in Tris-buffered saline (TBS; 0.1 M
Tris base, 0.1 M Tris–HCl, 0.6 M NaCl, pH 7.6) for 5 min.
This was followed by 20 min incubation with a 1:50 dilution
of horse-radish peroxidase-conjugated anti-mouse IgG
(AP124P Chemicon) at room temperature. Sections were
washed for a further 5 min and then antibody binding was
visualized by staining with 3,3″-diaminobenzidine (DAB
metal concentrate Roche) diluted 1:10 in peroxidase buffer
for 5 min at room temperature. Sections were counterstained
with hemotoxylin (Merck) and dehydrated through an 80 to
100% alcohol gradient, left in xylene for 16–20 h and
mounted in Depex (BDH).
Replication in RL-5 cells
RL-5 cells were infected with MSW at multiplicities of
infection (moi) of 0.1 and 0.01 by incubating the total number
of cells with the appropriate amount of virus in a final volume of
0.5 ml for 60 min with frequent gentle mixing. After incubation,the cells were washed twice in RPMI and then resuspended at
106/ml. One milliliter of this suspension was dispensed into
each of 8 wells of a 24 well plate and two 1 ml aliquots were
retained as time 0 samples. At 24, 48, 72, and 96 h after infec-
tion, the cells and supernatant were removed from two wells and
frozen at −70 °C. To release cell-associated virus, the cells were
freeze-thawed twice and sonicated. Virus titers were determined
by TCID50 assay on RK13 cell monolayers. In a separate ex-
periment, RL-5 cells were infected with MSW (moi 0.1) and 24
h after infection cells were fixed with methanol:acetone (1:1 v/
v) and then incubated with mAb3B6E4 for detection of myxoma
virus antigen. Antibody binding was detected with FITC-con-
jugated goat-anti-mouse Ig and visualized by fluorescence
microscopy.
Measurement of serum antibodies
Serum antibodies to myxoma virus were measured by
ELISA as described previously (Kerr, 1997).
Restriction fragment length analysis of MSD DNA
Viral DNA from MSD was prepared and analyzed as de-
scribed by Labudovic et al. (2004).References
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